These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 11738071)
1. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery. Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071 [TBL] [Abstract][Full Text] [Related]
2. Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery. Chen TT; Jiandong-Liu ; Wang G; Jiang SL; Li LB; Gao CQ Heart Surg Forum; 2013 Feb; 16(1):E38-47. PubMed ID: 23439357 [TBL] [Abstract][Full Text] [Related]
3. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Ray MJ; Marsh NA; Hawson GA Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673 [TBL] [Abstract][Full Text] [Related]
4. Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass. Ray MJ; Hales M; Marsh N Blood Coagul Fibrinolysis; 2001 Mar; 12(2):129-35. PubMed ID: 11302475 [TBL] [Abstract][Full Text] [Related]
5. Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass. Couturier R; Rubatti M; Credico C; Louvain-Quintard V; Anerkian V; Doubine S; Vasse M; Grassin-Delyle S Blood Coagul Fibrinolysis; 2014 Apr; 25(3):259-65. PubMed ID: 24418941 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation. Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942 [TBL] [Abstract][Full Text] [Related]
7. The kinetics of plasmin inhibition by aprotinin in vivo. Kang HM; Kalnoski MH; Frederick M; Chandler WL Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193 [TBL] [Abstract][Full Text] [Related]
8. Increased urokinase and consumption of α Longstaff C; Locke M J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372 [TBL] [Abstract][Full Text] [Related]
18. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584 [TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury. Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308 [TBL] [Abstract][Full Text] [Related]
20. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin. Ray MJ; Marsh NA Thromb Haemost; 1997 Sep; 78(3):1021-6. PubMed ID: 9308747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]